Particulate Matter (PM) Toxicology and Cardiopulmonary Disease

RoseyFields evaluates the toxicology of Particulate Matter using the following evidence base: EPA’s 2019 Integrated Science Assessment for Particulate Matter and its 2022 Supplement, ATSDR’s 2024 Guidance for Inhalation Exposures to Particulate Matter, and the underlying peer-reviewed animal toxicology and mechanistic literature those documents cite or that is otherwise part of the current PM toxicological database. This page addresses particulate matter (PM) as ATSDR’s own guidance frames the pollutant class — covering thoracic particles (PM10, mean aerodynamic diameter ≤ 10 μm) and their two principal size sub-fractions, fine particles (PM2.5, ≤ 2.5 μm) and thoracic coarse particles (PM10-2.5, >2.5 and ≤ 10 μm) — rather than PM2.5 in isolation; where the toxicological evidence diverges materially between these size fractions, that divergence is identified explicitly, since size fraction is the single most consequential determinant of PM toxicity (Section 1–2). As with RoseyFields’ companion PM2.5-focused pages, a structural note applies throughout: PM is not a single chemical but a size- and source-heterogeneous mixture, and its animal toxicological evidence functions primarily to establish mechanism and biological plausibility for the human epidemiological findings that drive PM regulation (see RoseyFields’ companion Risk Assessment Methodology and Epidemiology pages), rather than to supply a quantitative point of departure in the manner it would for a discrete IRIS chemical. Citations to specific findings and numeric values below are to the underlying peer-reviewed studies rather than to the ATSDR or EPA source documents.

1. Chemical Identity and Physicochemical Properties Relevant to Toxicity

Particulate matter is an operationally defined class of airborne solid particles and liquid droplets, classified by aerodynamic diameter into ultrafine particles (≤ 0.1 μm, not separately addressed in current ATSDR or EPA regulatory guidance because of limited atmospheric lifetime and characterization difficulty), fine particles (PM2.5, ≤ 2.5 μm), and thoracic particles (PM10, ≤ 10 μm, comprising PM2.5 plus the coarse fraction PM10-2.5, particles greater than 2.5 and up to 10 μm). These size categories are not mutually exclusive cut points but nested fractions — PM2.5 is a subset of PM10 — and PM composition varies substantially by size fraction as well as by source, time, region, and meteorology. PM2.5 tends to be dominated by combustion-derived and secondarily formed constituents (sulfates, nitrates, ammonium, elemental and organic carbon, and combustion-derived trace metals) and, because of its smaller particle size, travels much greater distances in the atmosphere and more often reflects regional rather than local air quality. PM10-2.5 (coarse particles) is generated predominantly by mechanical processes — windblown dust, road dust resuspension, agricultural activity, sea spray, and biological material (pollen, mold spores, plant and insect fragments) — and tends to be more locally sourced and shorter-lived in the atmosphere, with a chemical profile enriched in crustal elements (silicon, aluminum, calcium, iron) and biological constituents (endotoxin) relative to PM2.5.

Particle size is the principal physicochemical determinant of PM toxicity, governing both respiratory tract deposition pattern (Section 2) and the surface-area-to-mass ratio that determines catalytic reactive oxygen species generation capacity per unit particle mass; because surface area increases sharply as particle diameter decreases, the fine and ultrafine fractions are generally, though not uniformly, considered more biologically reactive per unit mass than the coarse fraction, although coarse particles carry their own distinct toxicological profile driven by different mechanisms (Section 3, Section 4). Neither PM2.5 nor PM10-2.5 constituents are appreciably biodegraded once deposited in tissue; the inorganic, crustal, and elemental carbon components in particular are essentially persistent, and poorly soluble carbonaceous particles have been shown to progressively accumulate in the lung with continued exposure, a phenomenon termed “particle overload” when clearance mechanisms become saturated (Morrow, 1988) — a species-dependent dosimetric phenomenon directly relevant to interpreting high-dose rat inhalation carcinogenicity bioassays (Section 5, Section 6). PM does not classically “bioaccumulate” up a food chain, since exposure is exclusively via inhalation and toxicity is governed by deposited lung and translocated systemic burden rather than dietary biomagnification; however, poorly soluble constituents of both size fractions can accumulate progressively within an individual organism’s lung tissue, associated lymph nodes, and, for the fine and ultrafine fractions specifically, extrapulmonary organs over the course of chronic exposure (Section 2).

2. Toxicokinetics: Absorption, Distribution, Metabolism, and Excretion

2.1 Respiratory Tract Deposition (Absorption Analog) — The Central Size Fraction Divergence

For an inhaled particulate mixture, respiratory tract deposition functions as the toxicokinetic analog of absorption, and this is the point at which PM10-2.5 (coarse) and PM2.5 (fine) toxicokinetics diverge most fundamentally. Coarse particles, because of their larger aerodynamic diameter, deposit predominantly by inertial impaction in the upper airway (nasopharyngeal and large conducting airway) region; a substantial fraction is cleared relatively quickly by mucociliary transport and swallowed, and coarse particles are not generally considered to cross into systemic circulation directly, although soluble constituents (leached metals, endotoxin, and other biologically active material) can be released into the airway lining fluid and produce local and, through secondary inflammatory signaling, systemic effects even without the particle itself translocating. Fine (PM2.5) particles deposit more efficiently in the tracheobronchial and alveolar regions of the lower respiratory tract, where clearance is slower (principally via alveolar macrophage phagocytosis rather than mucociliary transport) and systemic translocation potential is substantially greater; ultrafine particles (a PM2.5 subset) are deposited throughout the respiratory tract predominantly by diffusion, with especially efficient alveolar deposition. This size-dependent deposition pattern is well characterized across species using regional deposition modeling and is a central input to interspecies dosimetric comparisons (Section 6), because deposition fraction and pattern differ measurably between rodents (obligate nose breathers with different airway branching geometry) and humans (who breathe through both nose and mouth), independent of any difference in underlying tissue sensitivity.

2.2 Distribution and Translocation

Following deposition, the fine and ultrafine fractions of PM, but not the coarse fraction, can translocate beyond the respiratory tract to extrapulmonary organs, a distinction central to explaining why PM2.5 (and its ultrafine subset) produces well-documented systemic cardiovascular and neurological effects while PM10-2.5 does not, or does so through a more indirect route. Using isotopically labeled ultrafine elemental carbon particles (36 nm count median diameter) administered by inhalation to rats, Oberdörster et al. (2004) demonstrated two translocation pathways operating specifically for the fine/ultrafine fraction: alveolar-deposited particles translocated to pulmonary interstitial sites and to extrapulmonary organs, including the liver, within 4 to 24 hours; and, independently, particles depositing on the olfactory mucosa translocated directly along the olfactory nerve into the olfactory bulb of the brain, bypassing the blood-brain barrier, with approximately 20% of the olfactory-mucosa-deposited dose estimated to reach the olfactory bulb by this route. By contrast, coarse particles, which deposit predominantly in the upper airway rather than the alveolar or olfactory regions and are not efficiently phagocytosed and translocated by alveolar macrophages, are understood to affect systemic organs, where they do so at all, principally through indirect pathways: leached soluble constituents (metals, endotoxin) triggering local airway inflammation and systemic release of pro-inflammatory cytokines, rather than through direct particle translocation. Consistent with this indirect mechanism, Ljubimova et al. (2018), directly comparing coarse (PM2.5-10), fine (PM<2.5), and ultrafine PM fractions collected from ambient Los Angeles Basin air in a single controlled rat inhalation study, found that all three size fractions produced measurable cerebral accumulation of the metals nickel, cobalt, and zinc following intermediate-duration (1–3 month) exposure, but that upregulation of inflammatory and tumorigenesis-related gene expression (including the oncogene RAC1) in brain tissue was observed only following coarse particle exposure, not ultrafine particle exposure, despite comparable cerebral metal accumulation across fractions — an unexpected and mechanistically important finding indicating that the biological consequence of particle-associated metal accumulation in the brain depends on factors beyond metal burden alone (potentially the co-occurring soluble/biological constituent profile of the coarse fraction specifically) and that size-fraction-specific toxicity cannot always be predicted simply from the assumption that smaller particles are uniformly more biologically active.

2.3 Metabolism

PM, as a physical particulate mixture rather than a single organic chemical, does not undergo metabolism in the classical xenobiotic biotransformation sense as a bulk material for either size fraction; however, specific organic constituents adsorbed to particle surfaces — most importantly polycyclic aromatic hydrocarbons and related combustion-derived organic compounds, present predominantly in the fine fraction given its combustion-source dominance (Section 1) — undergo cytochrome P450-mediated metabolic activation to reactive, DNA-damaging intermediates following release from the particle surface within lung tissue, a pathway addressed in detail in RoseyFields’ companion benzo[a]pyrene toxicology page and directly relevant to the mutagenic and carcinogenic potential of the organic-carbon-rich fine fraction specifically (Section 4, Section 5).

2.4 Excretion and Clearance

Clearance of deposited PM differs by respiratory tract region, particle size, and species. Coarse particles deposited in the upper and central conducting airways are cleared relatively efficiently by mucociliary transport, typically within hours to a day or two. Fine particles deposited in the alveolar region are cleared far more slowly, principally by alveolar macrophage phagocytosis and subsequent transport to the mucociliary escalator or to pulmonary lymph nodes, a process that can take weeks to months and that becomes progressively less efficient as particle lung burden increases. At sufficiently high, sustained fine-particle exposure concentrations — well above typical ambient levels but relevant to the high-dose chronic rat inhalation bioassays discussed in Section 5 — alveolar macrophage mediated clearance can become overwhelmed (“particle overload”), resulting in disproportionate, non-linear increases in lung particle retention, secondary inflammation, and, in rats specifically, an associated increase in lung tumor incidence not observed in similarly exposed mice, hamsters, or primates (Morrow, 1988; Section 5). This species-specific clearance-overload phenomenon is a central toxicokinetic consideration for interpreting the fine particle (and diesel particulate, used as a fine-PM surrogate) animal carcinogenicity database, and has no clear coarse-particle analog given coarse particles’ comparatively efficient upper-airway clearance pathway.

3. Mechanism(s) of Action / Mode of Action

PM does not act through a single unifying mechanism; the mechanistic literature converges on a small number of interrelated pathways, several of which operate differently, or to different degrees, across the fine and coarse size fractions.

3.1 Pulmonary Oxidative Stress and Inflammation (Both Fractions, Different Emphasis)

The initiating event for most proposed PM mechanisms is generation of reactive oxygen species (ROS) at the particle-cell interface in the airway or lung, catalyzed by transition metals and redox-active organic constituents on the particle surface, together with ROS generated by activated macrophages and epithelial cells responding to deposited particles. For the fine fraction, this process is dominated by the combustion-derived carbon and metal constituents described in Section 1 and occurs principally in the alveolar region; for the coarse fraction, an analogous oxidative and inflammatory cascade occurs principally in the upper and central airway, initiated substantially by leached soluble metals undergoing Fenton-like reactions and by biological constituents such as endotoxin, which is disproportionately concentrated in the coarse fraction relative to fine PM (Ljubimova et al., 2018). Both pathways converge on activation of the redox-sensitive transcription factor NF-κB and downstream release of pro-inflammatory cytokines (e.g., IL-1β, IL-6, TNF-α), a response well documented across numerous rodent inhalation and instillation studies using both size fractions and using diesel exhaust particles as a well characterized fine-PM constituent and surrogate.

3.2 Systemic “Spillover” and Autonomic Nervous System Activation (Fine Fraction)

Two principal, non-mutually-exclusive mechanistic hypotheses connect pulmonary oxidative stress and inflammation to PM’s systemic cardiovascular effects, and both are documented predominantly using fine/PM2.5 or concentrated ambient particle (CAPs, predominantly fine-fraction) exposure paradigms rather than isolated coarse particle models, consistent with the coarse fraction’s more limited capacity for direct systemic translocation (Section 2.2). The first, a “spillover” hypothesis, proposes that pulmonary inflammatory mediators and, to a lesser degree, translocated fine/ultrafine particles or constituents enter systemic circulation and directly promote vascular inflammation, endothelial dysfunction, and a pro-thrombotic state at distant sites; exposure of naive mouse aortas ex vivo to plasma from CAPs-exposed mice was sufficient to activate vascular NF-κB signaling and induce insulin and vascular endothelial growth factor resistance, directly demonstrating transmission of a circulating inflammatory factor rather than requiring particle translocation itself. The second pathway implicates autonomic nervous system activation: in mice exposed to concentrated ambient PM2.5 for 6 months, chronic exposure significantly increased basal blood pressure, sympathetic tone (low-frequency blood pressure variability, urinary norepinephrine excretion), and pro-inflammatory NF-κB pathway activation specifically within the hypothalamic arcuate nucleus, indicating that fine-particle-induced central nervous system inflammation, potentially reaching the brain via the translocation pathways described in Section 2.2, can itself drive sustained sympathetic activation and hypertension.

3.3 Coarse-Particle-Specific Mechanistic Considerations

Because coarse particles do not efficiently translocate to extrapulmonary organs, their systemic and, notably, central nervous system effects (Section 2.2; Ljubimova et al., 2018) are understood to operate substantially through the same indirect, cytokine-mediated “spillover” pathway described in Section 3.2 for the fine fraction, rather than through direct particle delivery to the target organ — an inference supported by the Ljubimova et al. (2018) finding that coarse-particle-associated cerebral gene expression changes occurred despite the coarse fraction’s comparatively limited capacity for direct translocation, and despite ultrafine particles (with the greatest translocation capacity of all three fractions tested) producing no comparable transcriptional response, suggesting that soluble/biological constituent-driven signaling, rather than particle translocation per se, may be the dominant driver of this particular coarse-particle central nervous system effect.

3.4 Mode of Action for the Organic (PAH-Bearing) Fraction (Predominantly Fine Fraction)

For the polycyclic aromatic hydrocarbon-bearing organic fraction concentrated substantially in fine, combustion derived PM — a major contributor to diesel exhaust and other fine PM — a distinct, genotoxic mode of action operates in parallel to the oxidative-stress/inflammation pathways above: cytochrome P450-mediated metabolic activation of adsorbed PAHs to reactive diol-epoxide intermediates capable of forming DNA adducts and inducing mutations in tumor-relevant genes, addressed in detail in RoseyFields’ companion benzo[a]pyrene toxicology page and directly relevant to the carcinogenicity evidence in Section 5.

4. Animal Toxicological Evidence by Organ System

The following subsections summarize representative animal toxicology findings by organ system, noting size fraction-specific findings where the literature permits the comparison. As with RoseyFields’ companion PM2.5 Toxicology page, the animal database draws on several exposure paradigms of differing environmental realism: concentrated ambient particle (CAPs) systems (predominantly fine-fraction), instillation/aspiration of collected ambient or resuspended PM (used for both size fractions, including the direct fine/coarse/ultrafine comparison discussed in Section 2–3), and diesel exhaust particle inhalation, a data-rich, well-characterized fine-PM surrogate.

4.1 Respiratory (Pulmonary and Upper Airway)

The respiratory tract is the portal of entry for both size fractions and, unsurprisingly, the most extensively documented target organ, though the anatomic site of primary effect differs by fraction (Section 2.1). Chronic diesel exhaust inhalation in rats (a fine-PM surrogate) produces dose-related pulmonary inflammation, epithelial hyperplasia, and progressive fibrotic changes accompanying alveolar soot accumulation, with severity directly related to cumulative particle lung burden (Nikula et al., 1995; Mauderly et al., 1987); comparable chronic carbon black (elemental carbon surrogate, lacking diesel’s organic/PAH fraction) exposure produces qualitatively similar dose-related nonneoplastic pulmonary lesions of similar magnitude at equivalent particle mass, indicating that particle mass and surface area, not solely the organic chemical fraction, drive much of the fine-particle pulmonary inflammatory response (Nikula et al., 1995). Coarse particles, by contrast, produce their primary respiratory effects in the upper and central conducting airways rather than the alveolar region, consistent with their deposition pattern (Section 2.1); this upper-airway inflammatory response is a documented but comparatively less studied endpoint relative to the extensive alveolar-region fine-particle literature.

4.2 Cardiovascular (Predominantly Fine-Fraction Evidence)

PM’s cardiovascular animal toxicology database is unusually extensive and derives overwhelmingly from fine particle (CAPs or PM2.5 instillation) exposure paradigms, reflecting the priority placed on establishing mechanistic plausibility for the strong human fine-particle cardiovascular epidemiology (see companion Risk Assessment Methodology and Epidemiology pages). In spontaneously hypertensive rats, 15 weeks of CAPs exposure significantly increased blood pressure, decreased cardiac stroke volume and output, and increased heart weight together with cardiac hypertrophic marker expression, with these effects fully reversible upon exposure withdrawal (Ying et al., 2015). In C57BL/6J mice, 6 months of CAPs exposure significantly increased basal blood pressure and sympathetic tone via the hypothalamic inflammation mechanism described in Section 3.2. In hyperlipidemic mouse atherosclerosis models, 5 months of CAPs exposure (mean concentration 110 μg/m3) exacerbated aortic plaque development relative to filtered-air-exposed controls. Comparable dedicated coarse-particle cardiovascular inhalation bioassay data are considerably more limited in the current literature, consistent with the coarse fraction’s more limited direct systemic translocation capacity (Section 2.2) and the corresponding relative emphasis of the epidemiological literature on fine rather than coarse particle cardiovascular associations (companion Epidemiology page).

4.3 Neurological (Both Fractions, Divergent Mechanisms)

Neurological effects provide one of the clearest examples of size-fraction-specific findings in the entire PM toxicological database. As described in Section 2.2 and Section 3.3, Ljubimova et al. (2018) directly compared coarse (PM2.5-10), fine (PM<2.5), and ultrafine PM fractions collected from the same ambient source (Los Angeles Basin/Riverside, California air) in a single controlled rat study, exposing animals for short (2 weeks), intermediate (1–3 months), and long (1 year) durations. All three fractions produced measurable cerebral accumulation of nickel, cobalt, and zinc following intermediate-duration exposure, but upregulation of inflammatory (IL13-Rα1, IL-16) and tumorigenesis-related (EGR2, the oncogene RAC1) gene expression in brain tissue was observed only following coarse-particle exposure — not fine or ultrafine particle exposure, despite comparable cerebral metal burden across all three fractions. This finding is mechanistically important for two reasons: first, it demonstrates that coarse particles, despite their limited capacity for direct translocation to the brain (Section 2.2), can nonetheless produce measurable central nervous system molecular effects, presumably through the indirect, cytokine-mediated pathway described in Section 3.2–3.3; second, it demonstrates that particle size alone does not reliably predict the magnitude of a given toxicological endpoint, since the ultrafine fraction — with the greatest capacity for direct brain translocation via the olfactory pathway (Section 2.2; Oberdörster et al., 2004) — produced no significant inflammatory or oncogenic transcriptional response in this study despite comparable metal accumulation, indicating that the specific chemical/biological constituent profile of a given size fraction, not simply particle size or translocation efficiency, governs the resulting toxicological response for at least this endpoint.

4.4 Developmental / Neurodevelopmental (Fine Fraction)

Gestational fine-particle exposure has been repeatedly shown to produce structural and functional neurodevelopmental deficits in rodent offspring. In pregnant mice exposed to collected ambient PM2.5 via intratracheal instillation across gestation, high-dosage-exposed offspring showed impaired spatial memory in adolescence, ultrastructural hippocampal mitochondrial damage, decreased hippocampal neurogenesis, and dose dependent increases in neuronal and glial apoptosis accompanied by elevated hippocampal pro-inflammatory mediator expression (NF-κB, TNF-α, IL-1β) (Zheng et al., 2019). Sex-specific findings have also been reported, with prenatal PM2.5 exposure impairing spatial learning and memory specifically in male, but not female, mouse offspring, associated with disrupted cortical gene expression during postnatal developmental windows. Comparable coarse-particle developmental neurotoxicity data are largely absent from the current literature, which has focused overwhelmingly on the fine fraction for this endpoint.

4.5 Reproductive (Fine Fraction)

Male reproductive effects have been demonstrated using CAPs (fine-fraction) exposure in mice, with reductions in sperm concentration, motility, and normal morphology accompanied by a significant decline in plasma testosterone and reduced expression of testosterone-biosynthesis genes (StAR, P450scc, P450arom) and gonadotropin receptor genes in testicular tissue, indicating that fine-particle-associated sperm quality deficits are mechanistically linked to disrupted testosterone biosynthesis rather than direct cytotoxicity alone.

4.6 Immunological (Both Fractions)

Diesel exhaust particles (fine-PM surrogate) have been shown in rodent models to act as an adjuvant enhancing allergic sensitization: co-exposure to diesel exhaust particles and a model allergen (ovalbumin) enhances antigen specific IgE antibody production and airway hyperresponsiveness in mice significantly more than allergen exposure alone, a finding replicated across multiple independent rodent studies. Because the coarse fraction is disproportionately enriched in biological material (endotoxin, pollen, mold spores) relative to fine PM (Section 1), coarse particles are independently recognized as a potent direct trigger of innate immune and allergic airway responses through this biological constituent pathway, in addition to any adjuvant effect on sensitization to co administered antigens; both size fractions are therefore independently implicated in immune/allergic pulmonary effects, though through partially distinct constituent-driven mechanisms (particle-adsorbed organic/metal adjuvant activity for fine PM versus intrinsic biological constituent content for coarse PM).

5. Animal Carcinogenicity Bioassay Findings

The animal carcinogenicity database for combustion-derived particulate matter is dominated by chronic diesel exhaust inhalation bioassays in rats — a fine-particle surrogate — and provides the most extensive controlled exposure carcinogenicity evidence available for PM, illustrating a pronounced, mechanistically explicable species specific pattern of direct relevance to human risk interpretation. Dedicated chronic coarse-particle inhalation carcinogenicity bioassays are notably absent from the current literature, consistent with the coarse fraction’s comparatively limited alveolar deposition and organic/PAH carbon content (Section 1).

5.1 Rat: Positive and Reproducible (Fine Fraction/Diesel Surrogate)

Mauderly et al. (1987) exposed male and female F344 rats to whole diesel exhaust 7 hours/day, 5 days/week for 24 months at soot concentrations up to 6.6 mg/m3, finding a statistically significant, dose-related increase in lung tumor prevalence (13% at the high dose, 4% at the medium dose, versus 1% in controls), with four epithelial tumor types observed and a significant relationship between tumor prevalence and both exposure concentration and cumulative lung soot burden. Nikula et al. (1995), in a directly comparative design, exposed F344 rats to either whole diesel exhaust or aerosolized carbon black (elemental carbon surrogate, lacking diesel’s adsorbed organic/PAH fraction) at matched particle mass concentrations, and found that carbon black produced lung tumor incidence increases of similar magnitude to diesel exhaust in female rats, with incidence markedly lower in males than females for both particle types — indicating that particle mass and surface area burden, rather than the diesel-specific organic/PAH fraction, is the dominant driver of the rat lung tumor response, and that sex is an important effect modifier.

5.2 Mouse and Hamster: Negative Under Comparable Exposure Conditions

In a bioassay conducted in parallel with, and using the identical diesel exhaust exposure protocol as, the positive F344 rat study above, Mauderly et al. (1996) exposed CD-1 mice to whole diesel exhaust for 24 months at soot concentrations up to 7.1 mg/m3; despite mouse lungs accumulating soot burdens comparable to those in the positive rat bioassay, diesel exhaust exposure did not increase lung tumor incidence in mice at any dose. This negative mouse finding, together with independently reported negative or markedly attenuated findings in Syrian hamsters exposed under comparable heavy chronic diesel exhaust conditions, establishes that the rat lung tumor response to chronic, high-concentration fine carbonaceous particle inhalation is not a generalizable mammalian carcinogenic response but is substantially species-specific.

5.3 Mechanistic Basis for the Species Difference: The “Lung Overload” Phenomenon

The rat-specific carcinogenic response is substantially attributable to the particle clearance-overload phenomenon introduced in Section 2.4: at the high, sustained fine-particle mass concentrations used in these chronic bioassays, rat alveolar macrophage-mediated clearance becomes progressively impaired as lung particle burden increases, producing disproportionate particle retention, sustained pulmonary inflammation, and epithelial proliferation that promotes tumor development — a self-reinforcing, dose-dependent pathological cascade specific to the rat’s particle clearance kinetics and alveolar lung anatomy rather than a direct genotoxic response to the particles themselves (Morrow, 1988). Consistent with this species-specific dosimetric explanation, Nikula et al. (1997), comparing rats and cynomolgus monkeys exposed chronically to identical diesel exhaust and coal dust atmospheres, found that lung tissue responses and the anatomic sites of particle retention differed substantially between species, with rats showing a pattern of alveolar interstitial particle sequestration and associated pathology not replicated in the primate model — directly relevant to extrapolating the rat fine-particle carcinogenicity data to humans, whose respiratory tract anatomy and particle clearance kinetics are considered more comparable to the primate than the rodent pattern. Because this overload phenomenon is specific to the alveolar deposition and clearance pathway used predominantly by the fine fraction, it has no established analog for coarse-particle carcinogenicity, for which, as noted above, essentially no chronic inhalation bioassay data exist.

6. Comparison of Animal-Derived Findings to Human Epidemiological Evidence

PM presents a distinctive, and in some respects inverted, version of the animal-versus-human divergence problem relative to a typical IRIS chemical. For most IRIS chemicals, animal bioassay data provide the primary quantitative dose-response foundation, with human epidemiology in a corroborating role; for PM, as detailed in RoseyFields’ companion Risk Assessment Methodology page, the reverse is true — very large, long-duration human cohort studies provide the quantitative concentration-response foundation for regulatory standard-setting, predominantly for the fine (PM2.5) fraction, while the animal database serves primarily to establish mechanistic plausibility and biological coherence for those human findings.

Where genuine divergence arises between the animal and human evidence, it is concentrated in two areas, both discussed above. First is the species-specific rat lung carcinogenicity finding (Section 5): the clear, reproducible rat lung tumor response to chronic high-concentration carbonaceous (fine) particle inhalation does not appear in mice, hamsters, or primates exposed under comparable conditions, and is mechanistically attributable substantially to a rat-specific particle clearance-overload phenomenon operating at exposure concentrations many orders of magnitude above typical ambient fine-particle concentrations. This means the positive rat bioassay data, considered in isolation, would substantially overstate low-dose human lung cancer risk if applied without correction for the overload phenomenon and the large exposure-concentration gap between the bioassay and ambient conditions — which is precisely why EPA’s and IARC’s human carcinogenicity conclusions for PM and diesel exhaust particulate rely primarily on human epidemiology, supported by mechanistic and lower-dose animal data, rather than on direct quantitative extrapolation from high-dose rat bioassays.

Second, a distinctive fraction-specific divergence exists between the animal and human evidence bases themselves: the animal toxicology literature is overwhelmingly weighted toward the fine fraction (Sections 4–5), while the coarse fraction’s animal database is comparatively thin, limited substantially to upper-airway inflammation studies and the single controlled fine/coarse/ultrafine comparative study discussed in Sections 2–4 (Ljubimova et al., 2018). This asymmetry roughly parallels, but is not identical to, the human epidemiological evidence, which is also considerably more extensive and consistent for PM2.5 than for PM10-2.5 (companion Epidemiology page); however, ATSDR’s current screening guidance nonetheless retains a distinct coarse-particle (PM10) comparison value, based substantially on the qualitatively established but more limited coarse-particle evidence base, illustrating that regulatory practice does not simply default to treating the coarse fraction as non-hazardous merely because its animal and human evidence bases are less mature than those for PM2.5 — a distinction RoseyFields’ risk assessors should preserve rather than collapse when a specific matter involves coarse-particle-dominant exposure (e.g., certain occupational dust, agricultural, or mining exposure scenarios) rather than combustion-derived fine-particle exposure.

Toxicokinetic differences also contribute to animal-human divergence in ways distinct from typical interspecies metabolic differences: because respiratory tract anatomy, airway branching geometry, and particle clearance kinetics differ measurably between rodents and humans for both size fractions (Section 2.1, Section 5.3), a given ambient mass concentration does not necessarily produce equivalent regional lung tissue dose across species for either fraction, independent of any difference in underlying tissue sensitivity to a given local dose — a dosimetric source of divergence addressed in the human risk assessment context principally through species-specific regional deposition modeling rather than through a chemical-specific PBPK model of the kind used for systemically absorbed IRIS chemicals.

7. Data Gaps and Areas of Ongoing Research

• Coarse-particle (PM10-2.5) animal database: relative to the extensive fine-particle literature summarized in Sections 4–5, dedicated coarse-particle animal toxicology — particularly chronic inhalation carcinogenicity bioassay data, cardiovascular effects data, and systematic organ-system dose-response characterization — remains comparatively sparse, limiting the ability to independently corroborate or characterize coarse-particle-specific hazard beyond the upper-airway inflammatory and limited neurological (Ljubimova et al., 2018) evidence currently available.
• Compositional attribution across both fractions: because PM composition varies substantially by source, region, and size fraction, and because most animal studies use a single collected ambient sample or a diesel exhaust surrogate, the relative toxicological contribution of specific constituents (individual transition metals, organic carbon, secondary aerosol components, endotoxin and other biological constituents) remains incompletely characterized for either fraction, and current evidence cannot fully support source- or composition-specific risk differentiation for regulatory or litigation purposes.
• Mechanistic basis for the Ljubimova et al. (2018) coarse-versus-ultrafine divergence: the finding that coarse, but not ultrafine, PM exposure produced significant cerebral inflammatory/oncogenic gene expression despite comparable metal accumulation across fractions is an important but as-yet mechanistically unresolved observation, warranting further research into what specific coarse-particle constituent or combination of constituents (beyond the metals common to all three tested fractions) drives this differential response, and whether the finding generalizes beyond the single geographic PM source (Los Angeles Basin/Riverside, California) tested.
• Low-concentration animal dose-response data: as with the human epidemiological literature (companion Risk Assessment Methodology page), most animal PM toxicology studies for both fractions use exposure concentrations at or above typical ambient levels to achieve adequate statistical power within feasible study durations; comparatively little controlled animal dose-response data exists at the low ambient concentrations of greatest current regulatory interest, limiting the animal database’s ability to independently corroborate the absence of a low concentration threshold identified in the fine-particle human cohort literature.
• Sex-specific and life-stage-specific mechanistic characterization: several findings summarized above (marked sex differences in rat lung tumor incidence, Section 5.1; sex-specific developmental neurotoxicity, Section 4.4) indicate that PM toxicity, at least for the fine fraction, is not uniform across sex or developmental stage, but the mechanistic basis for these differences remains incompletely characterized for either fraction, and systematic sex- and life-stage stratified dose-response data remain limited relative to the overall size of the fine-particle toxicology literature, and are essentially absent for the coarse fraction.
• Interspecies dosimetric model refinement: while regional respiratory tract deposition modeling (Section 2.1) provides a qualitative and, for some applications, quantitative basis for cross-species comparison for both fractions, further refinement of species-specific clearance kinetics — particularly better characterization of the concentration thresholds at which particle clearance overload occurs across species for the fine fraction (Section 2.4, Section 5.3), and of coarse-particle upper-airway clearance kinetics across species — remains an active area of research relevant to ensuring animal bioassay findings are not inappropriately extrapolated to low-dose human exposure without correction for these species-specific dosimetric factors.

References